Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan B Angel

Showing results (21-30 of 136) with videos related to

Pageof 14
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2010
Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infectionAngela M Crawley, Sylvie Faucher, Jonathan B Angel
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 11, 2025
Pritelivir for the Treatment of Nucleoside Analogue-Resistant Orolabial Herpes Simplex Virus 2 in a Person Living with HIVAndrew Purssell, Kennedy Leung, Pierre Giguère, et al.
Immunology|August 3, 2010
Interleukin-7 enhances memory CD8(+) T-cell recall responses in health but its activity is impaired in human immunodeficiency virus infectionAlison M O'Connor, Angela M Crawley, Jonathan B Angel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2002
Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virusCurtis L Cooper, M A Parbhakar, Jonathan B Angel
Cellular Immunology|August 31, 2002
Active cellular infection of myeloid cells is required for HIV-1-mediated suppression of interleukin-12 p40 expressionKelley A Chambers, Karl G Parato, Jonathan B Angel
Journal of Leukocyte Biology|December 24, 2010
IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infectionAgatha Vranjkovic, Angela M Crawley, Andrea Patey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2019
Medical Assistance in Death as a Unique Opportunity to Advance Human Immunodeficiency Virus Cure ResearchTeslin S Sandstrom, Stephanie C Burke Schinkel, Jonathan B Angel
HIV Clinical Trials|March 6, 2004
The efficacy of calcium carbonate in the treatment of protease inhibitor-induced persistent diarrhea in HIV-infected patientsMegan J Turner, Jonathan B Angel, Kirsten Woodend, et al.
European Journal of Immunology|March 5, 2010
Interleukin-4 downregulates CD127 expression and activity on human thymocytes and mature CD8+ T cellsAngela M Crawley, Agatha Vranjkovic, Charlene Young, et al.
International Immunology|November 18, 2008
IL-2 receptor gamma chain cytokines differentially regulate human CD8+CD127+ and CD8+CD127- T cell division and susceptibility to apoptosisAngela M Crawley, Tanya Katz, Karl Parato, et al.
Pageof 14

Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2010
Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infectionAngela M Crawley, Sylvie Faucher, Jonathan B Angel
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 11, 2025
Pritelivir for the Treatment of Nucleoside Analogue-Resistant Orolabial Herpes Simplex Virus 2 in a Person Living with HIVAndrew Purssell, Kennedy Leung, Pierre Giguère, et al.
Immunology|August 3, 2010
Interleukin-7 enhances memory CD8(+) T-cell recall responses in health but its activity is impaired in human immunodeficiency virus infectionAlison M O'Connor, Angela M Crawley, Jonathan B Angel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2002
Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virusCurtis L Cooper, M A Parbhakar, Jonathan B Angel
Cellular Immunology|August 31, 2002
Active cellular infection of myeloid cells is required for HIV-1-mediated suppression of interleukin-12 p40 expressionKelley A Chambers, Karl G Parato, Jonathan B Angel
Journal of Leukocyte Biology|December 24, 2010
IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infectionAgatha Vranjkovic, Angela M Crawley, Andrea Patey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2019
Medical Assistance in Death as a Unique Opportunity to Advance Human Immunodeficiency Virus Cure ResearchTeslin S Sandstrom, Stephanie C Burke Schinkel, Jonathan B Angel
HIV Clinical Trials|March 6, 2004
The efficacy of calcium carbonate in the treatment of protease inhibitor-induced persistent diarrhea in HIV-infected patientsMegan J Turner, Jonathan B Angel, Kirsten Woodend, et al.
European Journal of Immunology|March 5, 2010
Interleukin-4 downregulates CD127 expression and activity on human thymocytes and mature CD8+ T cellsAngela M Crawley, Agatha Vranjkovic, Charlene Young, et al.
International Immunology|November 18, 2008
IL-2 receptor gamma chain cytokines differentially regulate human CD8+CD127+ and CD8+CD127- T cell division and susceptibility to apoptosisAngela M Crawley, Tanya Katz, Karl Parato, et al.
Pageof 14